Skip to main content
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. — Investor Relations & Filings

Ticker · CLRB ISIN · US15117F8077 LEI · 5493000NFZCRG7BYQV93 US Manufacturing
Open in API
Filings indexed 1,033 across all filing types
Latest filing 2010-10-19 Share Issue/Capital Cha…
Country US United States of America
Listing US CLRB

About Cellectar Biosciences, Inc.

https://www.cellectar.com/

Cellectar Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted cancer treatments. The company's core technology is a proprietary Phospholipid Drug Conjugate (PDC) platform that selectively delivers therapeutic payloads, such as radioisotopes and cytotoxins, to cancer cells by targeting lipid rafts in their plasma membranes. This approach is designed to maximize antitumor activity while minimizing off-target effects on healthy tissue. Cellectar's lead product candidate is iopofosine I 131, a first-in-class PDC that delivers the radioisotope iodine-131. It is being developed for the treatment of hematologic malignancies and has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for Waldenstrom's Macroglobulinemia.

Recent filings

Filing Released Lang Actions
Share Issue/Capital Change 2010
Share Issue/Capital Change Classification · 95% confidence The document is a 'Prospectus Supplement' filed pursuant to Rule 424(b)(3), which is a type of SEC filing used to update or supplement a previously filed prospectus. It discusses an increase in authorized shares of common stock and details the shareholder vote results from a special meeting. The document is relatively short (2238 characters) and focuses on share issuance and capital structure changes. It is not a full financial report, earnings release, or management discussion. The key content is about the increase in authorized shares and shareholder approval, which aligns with announcements related to capital changes. Therefore, the document fits best under 'Share Issue/Capital Change' (SHA).
2010-10-19 English
Declaration of Voting Results & Voting Rights Announcements 2010
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated October 18, 2010. It reports on a special meeting of stockholders where an amendment to the certificate of incorporation was approved to increase authorized shares. The document includes voting results and mentions the filing of the amendment with the Delaware Secretary of State. The content focuses on corporate governance changes related to share authorization and voting results. It is not a full annual or quarterly report, nor an earnings release or audit report. It is not a proxy solicitation or AGM material. The key content is the submission of matters to a vote of security holders and the amendment to articles of incorporation. This fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides official results from a shareholder vote and details on the voting outcome and subsequent filing. The document length is 3364 characters, which is sufficient to contain substantive voting results rather than just an announcement of a report. Therefore, the classification is DVA with high confidence.
2010-10-19 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-Q Quarterly Report filed with the SEC for the quarter ended June 30, 2010. It contains detailed financial statements including balance sheets, statements of operations, and cash flows, as well as management's discussion and analysis, legal proceedings, risk factors, and other substantive financial data. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement or certification. The presence of actual financial data and analysis confirms it is a comprehensive interim financial report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2010-08-13 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Q2 2010
2010-08-13 English
Capital/Financing Update 2010
Capital/Financing Update Classification · 95% confidence The document is a 'Prospectus Supplement' filed pursuant to Rule 424(b)(3), which is a type of SEC filing used to update or supplement a previously filed prospectus. It details the completion of a sale of common stock and warrants, including the number of shares, warrants, exercise prices, gross proceeds, and net proceeds. The document references securities purchase agreements and consent from preferred stockholders. The content focuses on financing activities and capital raising. The document length is 2082 characters, which is relatively short and consistent with a supplement or update rather than a full report. Given these characteristics, the document fits best under 'Capital/Financing Update' (CAP) as it provides an update on the company's fundraising and capital structure changes rather than being a full prospectus or annual report.
2010-07-29 English
Capital/Financing Update 2010
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated July 27, 2010, reporting the completion of a securities sale transaction including common stock and warrants. The content focuses on a financing event, specifically the sale of shares and warrants, net proceeds, and related consents from preferred stockholders. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The document is not a report publication announcement or certification but a current report on a capital raising event. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 2829 characters, which is consistent with a typical 8-K filing for such an event.
2010-07-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.